Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tor Shwayder

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of the American Academy of Dermatology|June 6, 2003
Graftskin therapy in epidermolysis bullosaDavid P Fivenson, Lubomira Scherschun, Michelle Choucair, et al.
Ophthalmology. Retina|August 18, 2019
Retinal Vascular Abnormalities in Phakomatosis PigmentovascularisAristomenis Thanos, Tor Shwayder, Thanos D Papakostas, et al.
Journal of the American Academy of Dermatology|July 8, 2021
Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomaliesOlivia M T Davies, Maria C Garzon, Ilona J Frieden, et al.
The Journal of Investigative Dermatology|January 23, 2013
Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cellLeopold Groesser, Eva Herschberger, Ana Sagrera, et al.
JAMA Dermatology|December 27, 2018
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North AmericaJames A Feinstein, Purevsuren Jambal, Kathleen Peoples, et al.
Journal of the American Academy of Dermatology|October 11, 2021
A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosaGregory Scott Phillips, Amy Huang, Bret D Augsburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of the American Academy of Dermatology|June 6, 2003
Graftskin therapy in epidermolysis bullosaDavid P Fivenson, Lubomira Scherschun, Michelle Choucair, et al.
Ophthalmology. Retina|August 18, 2019
Retinal Vascular Abnormalities in Phakomatosis PigmentovascularisAristomenis Thanos, Tor Shwayder, Thanos D Papakostas, et al.
Journal of the American Academy of Dermatology|July 8, 2021
Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomaliesOlivia M T Davies, Maria C Garzon, Ilona J Frieden, et al.
The Journal of Investigative Dermatology|January 23, 2013
Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cellLeopold Groesser, Eva Herschberger, Ana Sagrera, et al.
JAMA Dermatology|December 27, 2018
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North AmericaJames A Feinstein, Purevsuren Jambal, Kathleen Peoples, et al.
Journal of the American Academy of Dermatology|October 11, 2021
A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosaGregory Scott Phillips, Amy Huang, Bret D Augsburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
Pageof 6